Status:
RECRUITING
Retrospective Evaluation of Minimally-Invasive Surgical Strategies in Ovarian Neoplasms (REMISSION Study)
Lead Sponsor:
Jvan Casarin, MD PhD
Conditions:
Early-stage Epithelial Ovarian Cancer
Eligibility:
FEMALE
Brief Summary
This observational study aims to evaluate the outcomes of patients with early-stage epithelial ovarian cancer who are treated with minimally invasive surgery (such as laparoscopic or robotic surgery)....
Eligibility Criteria
Inclusion
- Patients with apparent early-stage epithelial ovarian cancer at preoperative evaluation
- Patients who underwent surgery between January 2014 and December 2023
- Patients who underwent open or minimally invasive surgical staging (Laparoscopic or Robotic-assisted approach) or restaging procedure
- Patients with final pathology report of Epithelial Ovarian Cancer
Exclusion
- Patients who have not performed a complete surgical staging
- Patients who underwent neoadjuvant chemotherapy
- Patients with invasive synchronous tumor
- Patients with no informed consent
- Patients with ASA class score of 4 or 5
Key Trial Info
Start Date :
May 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT06879730
Start Date
May 15 2024
End Date
October 1 2027
Last Update
March 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Filippo del Ponte
Varese, Varese, Italy, 21100